200 related articles for article (PubMed ID: 12634873)
1. Chronic heart failure as a metabolic disorder.
Anker SD; Al-Nasser FO
Heart Fail Monit; 2000; 1(2):42-9. PubMed ID: 12634873
[TBL] [Abstract][Full Text] [Related]
2. Neurohormonal regulation of cardiac ion channels in chronic heart failure.
Kurokawa J; Abriel H
J Cardiovasc Pharmacol; 2009 Aug; 54(2):98-105. PubMed ID: 19597366
[TBL] [Abstract][Full Text] [Related]
3. Cardiac cachexia.
Anker SD; Steinborn W; Strassburg S
Ann Med; 2004; 36(7):518-29. PubMed ID: 15513302
[TBL] [Abstract][Full Text] [Related]
4. Immune and neurohormonal pathways in chronic heart failure.
Sharma R; Anker SD
Congest Heart Fail; 2002; 8(1):23-8, 48. PubMed ID: 11821625
[TBL] [Abstract][Full Text] [Related]
5. Renal function as a predictor of prognosis in chronic heart failure.
Hillege H; Van Gilst W; de Zeeuw D; van Veldhuisen DJ
Heart Fail Monit; 2002; 2(3):78-84. PubMed ID: 12634888
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and therapy approaches of cardiac cachexia.
Springer J; Filippatos G; Akashi YJ; Anker SD
Curr Opin Cardiol; 2006 May; 21(3):229-33. PubMed ID: 16601462
[TBL] [Abstract][Full Text] [Related]
7. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
8. How does cachexia influence survival in cancer, heart failure and other chronic diseases?
Lainscak M; Podbregar M; Anker SD
Curr Opin Support Palliat Care; 2007 Dec; 1(4):299-305. PubMed ID: 18685379
[TBL] [Abstract][Full Text] [Related]
9. [Chronic heart failure and cachexia: role of endocrine system].
Dei Cas A; Muoio A; Zavaroni I
Minerva Cardioangiol; 2011 Dec; 59(6):601-12. PubMed ID: 19946251
[TBL] [Abstract][Full Text] [Related]
10. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
Doehner W; Bunck AC; Rauchhaus M; von Haehling S; Brunkhorst FM; Cicoira M; Tschope C; Ponikowski P; Claus RA; Anker SD
Eur Heart J; 2007 Apr; 28(7):821-8. PubMed ID: 17353227
[TBL] [Abstract][Full Text] [Related]
11. Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches.
Gong KZ; Song G; Spiers JP; Kelso EJ; Zhang ZG
Int J Clin Pract; 2007 Apr; 61(4):611-21. PubMed ID: 17394435
[TBL] [Abstract][Full Text] [Related]
12. Neurohumoral aspects of heart failure.
Benedict CR
Cardiol Clin; 1994 Feb; 12(1):9-23. PubMed ID: 7910114
[TBL] [Abstract][Full Text] [Related]
13. [Neuroimmunoendocrine interaction in the pathogenesis of chronic heart failure].
Poskrebysheva AS; Grinevich VV; Smurova IuV; Shostak NA; Akmaev IG
Usp Fiziol Nauk; 2003; 34(3):3-20. PubMed ID: 12942758
[TBL] [Abstract][Full Text] [Related]
14. [Activation of the renin-angiotensin-aldosterone system in heart failure].
Volpe M; Tocci G; Pagannone E
Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure.
Firdaus M; Bukhari N
J Okla State Med Assoc; 2003 Mar; 96(3):133-9. PubMed ID: 12688226
[TBL] [Abstract][Full Text] [Related]
16. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches.
Gullestad L; Aukrust P
Am J Cardiol; 2005 Jun; 95(11A):17C-23C; discussion 38C-40C. PubMed ID: 15925560
[TBL] [Abstract][Full Text] [Related]
17. Overview of emerging pharmacotherapy in chronic heart failure.
Szabó T; Felger D; von Haehling S; Lainscak M; Anker SD; Doehner W
Expert Opin Pharmacother; 2009 Sep; 10(13):2055-74. PubMed ID: 19606938
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
[TBL] [Abstract][Full Text] [Related]
19. Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!
Lainscak M; Doehner W; Anker SD
Eur J Heart Fail; 2007 Jan; 9(1):2-3. PubMed ID: 17027336
[TBL] [Abstract][Full Text] [Related]
20. [Role of immune inflammatory activity in chronic heart failure progress].
Mamamtavrishvili ND; Kvirkveliia AA; Abashidze RI; Sharashidze NS; Narsiia EV
Georgian Med News; 2008; (160-161):30-4. PubMed ID: 18711234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
